CLINICAL_TRIALS trial_result · 2017-04-27

Clinical Trial Update: PT003 MDI Dose Confirmation Study [Phase 2]

Phase 2 dose-confirmation study of PT003 MDI in Chronic Obstructive Pulmonary Disease has completed and its results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Pearl Therapeutics, Inc. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED | Results posted: 2017-04-27